Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.31 |
| ▸ | FBP1 | P09467 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22020406 | 0.98 | ESR1 (0.33) | ESR1ACHEGRIK1TSHRCA2 | |
| SCHEMBL22019488 | 0.96 | ACHE (0.35) | ESR1ACHEGRIK1ALOX5ESR2 | |
| SCHEMBL19002149 | 0.93 | ACHE (0.37) | ESR1ACHEGRIK1TSHRCA2 | |
| SCHEMBL18893073 | 0.93 | ACHE (0.37) | ESR1ACHEHDAC8ESR2 | |
| SCHEMBL30980792 | 0.93 | ACHE (0.37) | ESR1ACHEGRIK1TSHRCA2 | |
| SCHEMBL28595787 | 0.92 | HDAC8 (0.30) | ESR1HDAC8 | |
| SCHEMBL31072289 | 0.92 | HDAC8 (0.30) | ESR1HDAC8 | |
| SCHEMBL22019265 | 0.91 | PTPN5 (0.36) | ACHEGRIK1CA2HDAC8 | |
| SCHEMBL22020407 | 0.90 | ACVR1 (0.32) | ACVR1 | |
| SCHEMBL18893042 | 0.90 | HDAC8 (0.38) | ESR1ACHEGRIK1CA2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3406599-B1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2023-02-22 | — | — | EP | disclosed |
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | C1S, YAP1, ESR1 | ESR1 3/4885ACHE 1502/4885GRIK1 1679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.